As dysfunctions in protein homeostasis (proteostasis), leading to the accumulation of protein aggregates, are typical for AMD, PGC-1α may hold a promise as a therapy for AMD [63]. This evidence concerns the gene PPARGC1A and age-related macular degeneration.